Merck & Co. (MRK) Announces FDA Approval of KEYTRUDA® and KEYTRUDA QLEX™ Plus Paclitaxel, With or Without Bevacizumab, to Treat Adults With PD-L1+
Business
Archived
•
February 13, 2026
•
Source: https://finance.yahoo.com/rss/topstories - Read Original
"Because adventure is exploring the unknown"
"Monetize your website or boost your business with Code-Oryx. Join the network today!"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
